Our CEO, David Bloomfield features in this month's PharmaTimes magazine with a 3-page article discussing the challenges and realities of the disclosure data.
In his thought leader, David explains why disclosure should be a legislative requirement for all HCPs in the UK; why it's important for HCPs to be able to give all-important context for every payment they receive; and why further increasing the transparency of these financial arrangements can only be positive for the health industry and its stakeholders.
You can read the full article at: http://magazine.pharmatimes.com/#/reader/46829/177279 on pages 24 to 26